Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Sustained Decrease in Gastroenteritis-related Deaths and Hospitalizations in Children Less Than 5 Years of Age After the Introduction of Rotavirus Vaccination: A Time-Trend Analysis in Brazil (2001-2010).

Costa I, Linhares AC, Cunha MH, Tuboi S, Argüello DF, Justino MC, Gopala K, Ortega-Barria E, Colindres R.

Pediatr Infect Dis J. 2016 Jun;35(6):e180-90. doi: 10.1097/INF.0000000000001143.

PMID:
26991061
2.

Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.

Guerra SF, Linhares AC, Mascarenhas JD, Oliveira A, Justino MC, Soares LS, Müller EC, Brasil P, Tuboi S, Ortega-Barria E, Colindres R.

J Med Virol. 2015 Aug;87(8):1303-10. doi: 10.1002/jmv.24183. Epub 2015 Apr 16.

PMID:
25879653
3.

Loss to follow-up in a cohort of HIV-infected patients in a regional referral outpatient clinic in Brazil.

de Almeida MC, de Jesus Pedroso N, do Socorro Lina van Keulen M, Jácome GP, Fernandes GC, Yokoo EM, Tuboi SH.

AIDS Behav. 2014 Dec;18(12):2387-96. doi: 10.1007/s10461-014-0812-1.

PMID:
24917082
4.

Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data.

Paula AA, Schechter M, Tuboi SH, Faulhaber JC, Luz PM, Veloso VG, Moreira RI, Grinsztejn B, Harrison LH, Pacheco AG.

PLoS One. 2014 Apr 11;9(4):e94636. doi: 10.1371/journal.pone.0094636. eCollection 2014 Apr 11.

5.

Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, Brazil.

Pacheco AG, Saraceni V, Tuboi SH, Lauria LM, Moulton LH, Faulhaber JC, King B, Golub JE, Durovni B, Cavalcante S, Harrison LH, Chaisson RE, Schechter M.

AIDS Res Hum Retroviruses. 2011 Jan;27(1):25-8. doi: 10.1089/aid.2010.0089. Epub 2010 Oct 7.

6.

Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.

Cesar C, Shepherd BE, Krolewiecki AJ, Fink VI, Schechter M, Tuboi SH, Wolff M, Pape JW, Leger P, Padgett D, Madero JS, Gotuzzo E, Sued O, McGowan CC, Masys DR, Cahn PE; Caribbean, Central and South America Network for HIV Research (CCASAnet) Collaboration of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Program..

PLoS One. 2010 Jun 1;5(6):e10490. doi: 10.1371/journal.pone.0010490.

7.

Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, Brazil.

Merçon M, Tuboi SH, Batista SM, Telles SR, Grangeiro JR, Zajdenverg R, Lago RF, Barroso PF, Melo Mde F, Schechter M.

Braz J Infect Dis. 2009 Aug;13(4):272-5.

8.

Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.

Tuboi SH, Pacheco AG, Harrison LH, Stone RA, May M, Brinkhof MW, Dabis F, Egger M, Nash D, Bangsberg D, Braitstein P, Yiannoutsos CT, Wood R, Sprinz E, Schechter M; ARTLINC of IeDEA..

J Acquir Immune Defic Syndr. 2010 Jan;53(1):70-7. doi: 10.1097/QAI.0b013e3181c22d19.

9.

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

ART-LINC of IeDEA Study Group., Keiser O, Tweya H, Boulle A, Braitstein P, Schecter M, Brinkhof MW, Dabis F, Tuboi S, Sprinz E, Pujades-Rodriguez M, Calmy A, Kumarasamy N, Nash D, Jahn A, MacPhail P, Lüthy R, Wood R, Egger M.

AIDS. 2009 Sep 10;23(14):1867-74. doi: 10.1097/QAD.0b013e32832e05b2.

10.

Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients in 7 sites throughout Latin America and the Caribbean.

Tuboi SH, Schechter M, McGowan CC, Cesar C, Krolewiecki A, Cahn P, Wolff M, Pape JW, Padgett D, Madero JS, Gotuzzo E, Masys DR, Shepherd BE.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):615-23. doi: 10.1097/QAI.0b013e3181a44f0a.

11.

Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.

Pacheco AG, Tuboi SH, May SB, Moreira LF, Ramadas L, Nunes EP, Merçon M, Faulhaber JC, Harrison LH, Schechter M.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):624-30. doi: 10.1097/QAI.0b013e3181a4ecf5.

12.

Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil.

Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, Cavalcante SC, Durovni B, Faulhaber JC, Golub JE, King B, Schechter M, Harrison LH.

Am J Epidemiol. 2008 Dec 1;168(11):1326-32. doi: 10.1093/aje/kwn249. Epub 2008 Oct 9.

13.

Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.

Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N; Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group..

J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55. doi: 10.1089/jwh.2007.0353.

PMID:
18240981
14.

Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil.

Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M.

PLoS One. 2008 Jan 30;3(1):e1531. doi: 10.1371/journal.pone.0001531.

15.

Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.

Tuboi SH, Brinkhof MW, Egger M, Stone RA, Braitstein P, Nash D, Sprinz E, Dabis F, Harrison LH, Schechter M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):52-9.

PMID:
17460471
16.

Discordant immunological and virological responses to antiretroviral therapy.

Schechter M, Tuboi SH.

J Antimicrob Chemother. 2006 Sep;58(3):506-10. Epub 2006 Jul 19.

PMID:
16854959
17.

Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002.

Tuboi SH, Costa ZG, da Costa Vasconcelos PF, Hatch D.

Trans R Soc Trop Med Hyg. 2007 Feb;101(2):169-75. Epub 2006 Jun 30.

PMID:
16814821
18.

Waterborne toxoplasmosis, Brazil, from field to gene.

de Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, Carmo EH, Ramalho WM, Camargo NJ, Trevisan R, Graça RM, da Silva AJ, Moura I, Dubey JP, Garrett DO.

Emerg Infect Dis. 2006 Feb;12(2):326-9.

19.

Predictors of virologic failure in HIV-1-infected patients starting highly active antiretroviral therapy in Porto Alegre, Brazil.

Tuboi SH, Harrison LH, Sprinz E, Albernaz RK, Schechter M.

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):324-8.

PMID:
16249707

Supplemental Content

Loading ...
Support Center